DSC Advisors »

Teva Pharmaceutical Industries shares owned by DSC Advisors

Quarter-by-quarter ownership of Teva Pharmaceutical Industries (TEVA) shares owned by DSC Advisors from 13F filings

Historical chart of DSC Advisors investment in Teva Pharmaceutical Industries

Tip: Access up to 7 years of quarterly data

All positions including Teva Pharmaceutical Industries held by DSC Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Teva Pharmaceutical Industries by DSC Advisors

Quarter filed Position value Share count Share price at filing
2023-09-30 $3.0M 293k 10.20
2023-06-30 $2.3M 310k 7.53
2023-03-31 $1.6M 180k 8.85
2022-09-30 $726k 90k 8.07

More positions owned by DSC Advisors

CVS Caremark Corporation (CVS)
R1 RCM (RCM)
BioMarin Pharmaceutical (BMRN)
Zimmer Holdings (ZBH)
Abbott Laboratories (ABT)
eHealth (EHTH)
Vyne Therapeutics (VYNE)
Enhabit Ord (EHAB)
Adt Call Option (ADT)
United Sts Nat Gas Unit Par Call Option
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Microsoft Corporation (MSFT)
Visa Com Cl A (V)
Mastercard Incorporated Cl A (MA)

View all positions for DSC Advisors

Top funds holding Teva Pharmaceutical Industries

Ion Asset Management
Phoenix Holdings
Migdal Insurance & Financial Holdings
Harel Insurance Investments & Financial Services
Millennium Management
Citadel Advisors
AustralianSuper Pty
Sound Shore Management
Goldman Sachs Group
Abrams Capital Management
Soleus Capital Management
Alyeska Investment Group
Legal & General Group
Holocene Advisors
Meitav Dash Investments

View all funds holding Teva Pharmaceutical Industries